---
title: Prognostic scores for predicting overall survival in patients with metastatic
  renal and urothelial cancer undergoing immunotherapy - which one to use?
date: '2025-01-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39880915/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250130170945&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: mGPS, SII and NLR are scoring systems that are easy to record
  in routine clinical practice. As they provide good prediction of OS in patients
  with mUC and mRCC under IO, they may allow identification of patients at high-risk
  and monitor them more cautiously in addition to ...'
disable_comments: true
---
CONCLUSION: mGPS, SII and NLR are scoring systems that are easy to record in routine clinical practice. As they provide good prediction of OS in patients with mUC and mRCC under IO, they may allow identification of patients at high-risk and monitor them more cautiously in addition to ...